[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nausea And Vomiting Treatment Market Growth (Status and Outlook) 2024-2030

January 2024 | 107 pages | ID: G0D7AEA3B2EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Nausea And Vomiting Treatment market size was valued at US$ 5082.5 million in 2023. With growing demand in downstream market, the Nausea And Vomiting Treatment is forecast to a readjusted size of US$ 8025.1 million by 2030 with a CAGR of 6.7% during review period.

The research report highlights the growth potential of the global Nausea And Vomiting Treatment market. Nausea And Vomiting Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nausea And Vomiting Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nausea And Vomiting Treatment market.

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.

United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.

Key Features:

The report on Nausea And Vomiting Treatment market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Nausea And Vomiting Treatment market. It may include historical data, market segmentation by Type (e.g., Serotonin Receptor Antagonist, Neurokinin NK1 Receptor Antagonist), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nausea And Vomiting Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Nausea And Vomiting Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Nausea And Vomiting Treatment industry. This include advancements in Nausea And Vomiting Treatment technology, Nausea And Vomiting Treatment new entrants, Nausea And Vomiting Treatment new investment, and other innovations that are shaping the future of Nausea And Vomiting Treatment.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nausea And Vomiting Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Nausea And Vomiting Treatment product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nausea And Vomiting Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nausea And Vomiting Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nausea And Vomiting Treatment market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nausea And Vomiting Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nausea And Vomiting Treatment market.

Market Segmentation:

Nausea And Vomiting Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Serotonin Receptor Antagonist
  • Neurokinin NK1 Receptor Antagonist
  • Others
Segmentation by application
  • CINV
  • PONV
  • Motion Sickness
  • Pregnancy
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck & Co. Inc.
  • Helsinn Group
  • Unimed Pharmaceuticals (AbbVie Inc.)
  • Kyowa Kirin
  • Sanofi
  • Qilu Pharma
  • Teva Pharmaceutical Industries Ltd.
  • Taiji group
  • Novartis
  • Heron Therapeutics
  • Pharmanovia
  • Mylan
  • Duchesnay
  • GSK
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nausea And Vomiting Treatment Market Size 2019-2030
  2.1.2 Nausea And Vomiting Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nausea And Vomiting Treatment Segment by Type
  2.2.1 Serotonin Receptor Antagonist
  2.2.2 Neurokinin NK1 Receptor Antagonist
  2.2.3 Others
2.3 Nausea And Vomiting Treatment Market Size by Type
  2.3.1 Nausea And Vomiting Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
2.4 Nausea And Vomiting Treatment Segment by Application
  2.4.1 CINV
  2.4.2 PONV
  2.4.3 Motion Sickness
  2.4.4 Pregnancy
  2.4.5 Others
2.5 Nausea And Vomiting Treatment Market Size by Application
  2.5.1 Nausea And Vomiting Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)

3 NAUSEA AND VOMITING TREATMENT MARKET SIZE BY PLAYER

3.1 Nausea And Vomiting Treatment Market Size Market Share by Players
  3.1.1 Global Nausea And Vomiting Treatment Revenue by Players (2019-2024)
  3.1.2 Global Nausea And Vomiting Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Nausea And Vomiting Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NAUSEA AND VOMITING TREATMENT BY REGIONS

4.1 Nausea And Vomiting Treatment Market Size by Regions (2019-2024)
4.2 Americas Nausea And Vomiting Treatment Market Size Growth (2019-2024)
4.3 APAC Nausea And Vomiting Treatment Market Size Growth (2019-2024)
4.4 Europe Nausea And Vomiting Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Nausea And Vomiting Treatment Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Nausea And Vomiting Treatment Market Size by Country (2019-2024)
5.2 Americas Nausea And Vomiting Treatment Market Size by Type (2019-2024)
5.3 Americas Nausea And Vomiting Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nausea And Vomiting Treatment Market Size by Region (2019-2024)
6.2 APAC Nausea And Vomiting Treatment Market Size by Type (2019-2024)
6.3 APAC Nausea And Vomiting Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Nausea And Vomiting Treatment by Country (2019-2024)
7.2 Europe Nausea And Vomiting Treatment Market Size by Type (2019-2024)
7.3 Europe Nausea And Vomiting Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nausea And Vomiting Treatment by Region (2019-2024)
8.2 Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NAUSEA AND VOMITING TREATMENT MARKET FORECAST

10.1 Global Nausea And Vomiting Treatment Forecast by Regions (2025-2030)
  10.1.1 Global Nausea And Vomiting Treatment Forecast by Regions (2025-2030)
  10.1.2 Americas Nausea And Vomiting Treatment Forecast
  10.1.3 APAC Nausea And Vomiting Treatment Forecast
  10.1.4 Europe Nausea And Vomiting Treatment Forecast
  10.1.5 Middle East & Africa Nausea And Vomiting Treatment Forecast
10.2 Americas Nausea And Vomiting Treatment Forecast by Country (2025-2030)
  10.2.1 United States Nausea And Vomiting Treatment Market Forecast
  10.2.2 Canada Nausea And Vomiting Treatment Market Forecast
  10.2.3 Mexico Nausea And Vomiting Treatment Market Forecast
  10.2.4 Brazil Nausea And Vomiting Treatment Market Forecast
10.3 APAC Nausea And Vomiting Treatment Forecast by Region (2025-2030)
  10.3.1 China Nausea And Vomiting Treatment Market Forecast
  10.3.2 Japan Nausea And Vomiting Treatment Market Forecast
  10.3.3 Korea Nausea And Vomiting Treatment Market Forecast
  10.3.4 Southeast Asia Nausea And Vomiting Treatment Market Forecast
  10.3.5 India Nausea And Vomiting Treatment Market Forecast
  10.3.6 Australia Nausea And Vomiting Treatment Market Forecast
10.4 Europe Nausea And Vomiting Treatment Forecast by Country (2025-2030)
  10.4.1 Germany Nausea And Vomiting Treatment Market Forecast
  10.4.2 France Nausea And Vomiting Treatment Market Forecast
  10.4.3 UK Nausea And Vomiting Treatment Market Forecast
  10.4.4 Italy Nausea And Vomiting Treatment Market Forecast
  10.4.5 Russia Nausea And Vomiting Treatment Market Forecast
10.5 Middle East & Africa Nausea And Vomiting Treatment Forecast by Region (2025-2030)
  10.5.1 Egypt Nausea And Vomiting Treatment Market Forecast
  10.5.2 South Africa Nausea And Vomiting Treatment Market Forecast
  10.5.3 Israel Nausea And Vomiting Treatment Market Forecast
  10.5.4 Turkey Nausea And Vomiting Treatment Market Forecast
  10.5.5 GCC Countries Nausea And Vomiting Treatment Market Forecast
10.6 Global Nausea And Vomiting Treatment Forecast by Type (2025-2030)
10.7 Global Nausea And Vomiting Treatment Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Merck & Co. Inc.
  11.1.1 Merck & Co. Inc. Company Information
  11.1.2 Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
  11.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Merck & Co. Inc. Main Business Overview
  11.1.5 Merck & Co. Inc. Latest Developments
11.2 Helsinn Group
  11.2.1 Helsinn Group Company Information
  11.2.2 Helsinn Group Nausea And Vomiting Treatment Product Offered
  11.2.3 Helsinn Group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Helsinn Group Main Business Overview
  11.2.5 Helsinn Group Latest Developments
11.3 Unimed Pharmaceuticals (AbbVie Inc.)
  11.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Company Information
  11.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
  11.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Main Business Overview
  11.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
11.4 Kyowa Kirin
  11.4.1 Kyowa Kirin Company Information
  11.4.2 Kyowa Kirin Nausea And Vomiting Treatment Product Offered
  11.4.3 Kyowa Kirin Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Kyowa Kirin Main Business Overview
  11.4.5 Kyowa Kirin Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi Nausea And Vomiting Treatment Product Offered
  11.5.3 Sanofi Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 Qilu Pharma
  11.6.1 Qilu Pharma Company Information
  11.6.2 Qilu Pharma Nausea And Vomiting Treatment Product Offered
  11.6.3 Qilu Pharma Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Qilu Pharma Main Business Overview
  11.6.5 Qilu Pharma Latest Developments
11.7 Teva Pharmaceutical Industries Ltd.
  11.7.1 Teva Pharmaceutical Industries Ltd. Company Information
  11.7.2 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
  11.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
  11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.8 Taiji group
  11.8.1 Taiji group Company Information
  11.8.2 Taiji group Nausea And Vomiting Treatment Product Offered
  11.8.3 Taiji group Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Taiji group Main Business Overview
  11.8.5 Taiji group Latest Developments
11.9 Novartis
  11.9.1 Novartis Company Information
  11.9.2 Novartis Nausea And Vomiting Treatment Product Offered
  11.9.3 Novartis Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Novartis Main Business Overview
  11.9.5 Novartis Latest Developments
11.10 Heron Therapeutics
  11.10.1 Heron Therapeutics Company Information
  11.10.2 Heron Therapeutics Nausea And Vomiting Treatment Product Offered
  11.10.3 Heron Therapeutics Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Heron Therapeutics Main Business Overview
  11.10.5 Heron Therapeutics Latest Developments
11.11 Pharmanovia
  11.11.1 Pharmanovia Company Information
  11.11.2 Pharmanovia Nausea And Vomiting Treatment Product Offered
  11.11.3 Pharmanovia Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Pharmanovia Main Business Overview
  11.11.5 Pharmanovia Latest Developments
11.12 Mylan
  11.12.1 Mylan Company Information
  11.12.2 Mylan Nausea And Vomiting Treatment Product Offered
  11.12.3 Mylan Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Mylan Main Business Overview
  11.12.5 Mylan Latest Developments
11.13 Duchesnay
  11.13.1 Duchesnay Company Information
  11.13.2 Duchesnay Nausea And Vomiting Treatment Product Offered
  11.13.3 Duchesnay Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Duchesnay Main Business Overview
  11.13.5 Duchesnay Latest Developments
11.14 GSK
  11.14.1 GSK Company Information
  11.14.2 GSK Nausea And Vomiting Treatment Product Offered
  11.14.3 GSK Nausea And Vomiting Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 GSK Main Business Overview
  11.14.5 GSK Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Nausea And Vomiting Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Serotonin Receptor Antagonist
Table 3. Major Players of Neurokinin NK1 Receptor Antagonist
Table 4. Major Players of Others
Table 5. Nausea And Vomiting Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Nausea And Vomiting Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Table 8. Nausea And Vomiting Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Nausea And Vomiting Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Table 11. Global Nausea And Vomiting Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Nausea And Vomiting Treatment Revenue Market Share by Player (2019-2024)
Table 13. Nausea And Vomiting Treatment Key Players Head office and Products Offered
Table 14. Nausea And Vomiting Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nausea And Vomiting Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2019-2024)
Table 19. Global Nausea And Vomiting Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Nausea And Vomiting Treatment Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Nausea And Vomiting Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Nausea And Vomiting Treatment Market Size Market Share by Country (2019-2024)
Table 23. Americas Nausea And Vomiting Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Table 25. Americas Nausea And Vomiting Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Table 27. APAC Nausea And Vomiting Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Nausea And Vomiting Treatment Market Size Market Share by Region (2019-2024)
Table 29. APAC Nausea And Vomiting Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Table 31. APAC Nausea And Vomiting Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Table 33. Europe Nausea And Vomiting Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Nausea And Vomiting Treatment Market Size Market Share by Country (2019-2024)
Table 35. Europe Nausea And Vomiting Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Table 37. Europe Nausea And Vomiting Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Nausea And Vomiting Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Nausea And Vomiting Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Nausea And Vomiting Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Nausea And Vomiting Treatment
Table 46. Key Market Challenges & Risks of Nausea And Vomiting Treatment
Table 47. Key Industry Trends of Nausea And Vomiting Treatment
Table 48. Global Nausea And Vomiting Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Nausea And Vomiting Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Nausea And Vomiting Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Merck & Co. Inc. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 53. Merck & Co. Inc. Nausea And Vomiting Treatment Product Offered
Table 54. Merck & Co. Inc. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Merck & Co. Inc. Main Business
Table 56. Merck & Co. Inc. Latest Developments
Table 57. Helsinn Group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 58. Helsinn Group Nausea And Vomiting Treatment Product Offered
Table 59. Helsinn Group Main Business
Table 60. Helsinn Group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Helsinn Group Latest Developments
Table 62. Unimed Pharmaceuticals (AbbVie Inc.) Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 63. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Product Offered
Table 64. Unimed Pharmaceuticals (AbbVie Inc.) Main Business
Table 65. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Unimed Pharmaceuticals (AbbVie Inc.) Latest Developments
Table 67. Kyowa Kirin Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 68. Kyowa Kirin Nausea And Vomiting Treatment Product Offered
Table 69. Kyowa Kirin Main Business
Table 70. Kyowa Kirin Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Kyowa Kirin Latest Developments
Table 72. Sanofi Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 73. Sanofi Nausea And Vomiting Treatment Product Offered
Table 74. Sanofi Main Business
Table 75. Sanofi Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Sanofi Latest Developments
Table 77. Qilu Pharma Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 78. Qilu Pharma Nausea And Vomiting Treatment Product Offered
Table 79. Qilu Pharma Main Business
Table 80. Qilu Pharma Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Qilu Pharma Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd. Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 83. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Product Offered
Table 84. Teva Pharmaceutical Industries Ltd. Main Business
Table 85. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 87. Taiji group Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 88. Taiji group Nausea And Vomiting Treatment Product Offered
Table 89. Taiji group Main Business
Table 90. Taiji group Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Taiji group Latest Developments
Table 92. Novartis Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 93. Novartis Nausea And Vomiting Treatment Product Offered
Table 94. Novartis Main Business
Table 95. Novartis Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Novartis Latest Developments
Table 97. Heron Therapeutics Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 98. Heron Therapeutics Nausea And Vomiting Treatment Product Offered
Table 99. Heron Therapeutics Main Business
Table 100. Heron Therapeutics Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Heron Therapeutics Latest Developments
Table 102. Pharmanovia Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 103. Pharmanovia Nausea And Vomiting Treatment Product Offered
Table 104. Pharmanovia Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Pharmanovia Main Business
Table 106. Pharmanovia Latest Developments
Table 107. Mylan Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 108. Mylan Nausea And Vomiting Treatment Product Offered
Table 109. Mylan Main Business
Table 110. Mylan Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 111. Mylan Latest Developments
Table 112. Duchesnay Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 113. Duchesnay Nausea And Vomiting Treatment Product Offered
Table 114. Duchesnay Main Business
Table 115. Duchesnay Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 116. Duchesnay Latest Developments
Table 117. GSK Details, Company Type, Nausea And Vomiting Treatment Area Served and Its Competitors
Table 118. GSK Nausea And Vomiting Treatment Product Offered
Table 119. GSK Main Business
Table 120. GSK Nausea And Vomiting Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 121. GSK Latest Developments

LIST OF FIGURES

Figure 1. Nausea And Vomiting Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nausea And Vomiting Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nausea And Vomiting Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nausea And Vomiting Treatment Sales Market Share by Country/Region (2023)
Figure 8. Nausea And Vomiting Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nausea And Vomiting Treatment Market Size Market Share by Type in 2023
Figure 10. Nausea And Vomiting Treatment in CINV
Figure 11. Global Nausea And Vomiting Treatment Market: CINV (2019-2024) & ($ Millions)
Figure 12. Nausea And Vomiting Treatment in PONV
Figure 13. Global Nausea And Vomiting Treatment Market: PONV (2019-2024) & ($ Millions)
Figure 14. Nausea And Vomiting Treatment in Motion Sickness
Figure 15. Global Nausea And Vomiting Treatment Market: Motion Sickness (2019-2024) & ($ Millions)
Figure 16. Nausea And Vomiting Treatment in Pregnancy
Figure 17. Global Nausea And Vomiting Treatment Market: Pregnancy (2019-2024) & ($ Millions)
Figure 18. Nausea And Vomiting Treatment in Others
Figure 19. Global Nausea And Vomiting Treatment Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Nausea And Vomiting Treatment Market Size Market Share by Application in 2023
Figure 21. Global Nausea And Vomiting Treatment Revenue Market Share by Player in 2023
Figure 22. Global Nausea And Vomiting Treatment Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Nausea And Vomiting Treatment Market Size 2019-2024 ($ Millions)
Figure 24. APAC Nausea And Vomiting Treatment Market Size 2019-2024 ($ Millions)
Figure 25. Europe Nausea And Vomiting Treatment Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Nausea And Vomiting Treatment Market Size 2019-2024 ($ Millions)
Figure 27. Americas Nausea And Vomiting Treatment Value Market Share by Country in 2023
Figure 28. United States Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Nausea And Vomiting Treatment Market Size Market Share by Region in 2023
Figure 33. APAC Nausea And Vomiting Treatment Market Size Market Share by Type in 2023
Figure 34. APAC Nausea And Vomiting Treatment Market Size Market Share by Application in 2023
Figure 35. China Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Nausea And Vomiting Treatment Market Size Market Share by Country in 2023
Figure 42. Europe Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Figure 43. Europe Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Figure 44. Germany Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Nausea And Vomiting Treatment Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Nausea And Vomiting Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 58. APAC Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Europe Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 61. United States Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Canada Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 65. China Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Japan Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Korea Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 69. India Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Australia Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Germany Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 72. France Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 73. UK Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Italy Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Russia Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Spain Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 79. Israel Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Nausea And Vomiting Treatment Market Size 2025-2030 ($ Millions)
Figure 82. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Nausea And Vomiting Treatment Market Size Market Share Forecast by Application (2025-2030)


More Publications